Scientific, clinical, and commercial intelligence are at the core of our strategy practice.

We deliver clear, evidence-based strategic assessments that guide investment decisions, clinical prioritization, and business development direction. Our work integrates scientific, clinical, commercial, and financial signals to produce a confident, defensible strategy for growth.

Market & Landscape Assessment
Holistic mapping of therapeutic, competitive, and epidemiological dynamics to illuminate market drivers, saturation points, and emerging scientific approaches. We synthesize trial pipelines, mechanism trends, payer guidance, and real-world treatment behavior to identify strategic openings and risks.

Indication & Portfolio Strategy
Structured frameworks to prioritize indications, therapeutic segments, and sequencing options. We evaluate unmet needs, differentiation levers, commercial potential, and clinical feasibility to guide rational portfolio construction and strategic focus.

Valuation & Opportunity Sizing
Development of revenue models, TAM/SAM sizing, and risk-adjusted forecasts that quantify the commercial potential of assets or platforms. Our models integrate pricing assumptions, uptake curves, epidemiological foundations, and competitive constraints to support investment cases and portfolio decisions.

Commercial Scenario Planning
Simulation of pricing, reimbursement, and competitive dynamics across multiple launch conditions. We assess market access pathways, policy changes, competitor moves, and cross-asset dependencies to define resilient commercial strategies.

Partner Scouting & BD Preparation
Identification and prioritization of potential partners, aligned investors, or acquirers. We support BD outreach through positioning narratives, pitch materials, and competitive framing that communicate scientific value, commercial potential, and strategic fit.